Using light therapy to enhance walking in patients with peripheral artery disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ENLIGHTEN PAD Trial aims to evaluate the effectiveness of daily 660 nm light treatment applied to the lower extremities before home-based walking exercises in improving walking distance for individuals with peripheral artery disease (PAD). This Phase II multi-centered randomized clinical trial will compare the outcomes of participants receiving light therapy against those receiving sham light therapy over a four-month period. The study will also investigate the immediate effects of the light treatment on walking intensity and explore biological mechanisms that may enhance exercise benefits. Participants will be monitored for changes in walking distance and other health indicators related to muscle and vascular function.

Why it matters

Who can join: the full rules

Inclusion Criteria:

First, all participants will be age 50 and older. Second, all participants will have PAD. PAD will be defined as:

1. An ABI \<= 0.90 at baseline.
2. Vascular lab evidence of PAD (such as a toe brachial pressure \<= 0.70 or an ankle brachial index less than or equal to 0.90), or angiographic evidence of PAD defined as at least 70% stenosis of an artery supplying the lower extremities.
3. An ABI of \>0.90 and \<= 1.00 who experience a 20% or greater drop in ABI in either leg after the heel-rise test.

Exclusion Criteria:

1. Above- or below-knee amputation
2. Critical limb ischemia defined as an ABI \<0.40 with symptoms of rest pain
3. Wheelchair confinement or requiring a walker to ambulate
4. Walking is limited by a symptom other than PAD
5. Current foot ulcer on bottom of foot
6. Failure to successfully complete the study run-in
7. Planned major surgery, coronary or leg revascularization during the next four months
8. Major surgery, coronary or leg revascularization or major cardiovascular event in the previous three months
9. Major medical illness including lung disease requiring oxygen, Parkinson's disease, a life-threatening illness with life expectancy less than six months, or cancer requiring treatment in the previous two years. \[NOTE: potential participants may still qualify if they have had treatment for an early stage cancer in the past two years and the prognosis is excellent, unless the cancer is located in the lower extremities. Participants who require oxygen only at night may still qualify.\]
10. Mini-Mental Status Examination (MMSE) score \< 23
11. Non-English speaking
12. Participation in or completion of a clinical trial in the previous three months. \[NOTE: after completing a stem cell or gene therapy intervention, participants will become eligible after the final study follow-up visit of the stem cell or gene therapy study so long as at least six months have passed since the final intervention administration. After completing a supplement or drug therapy (other than stem cell or gene therapy), participants will be eligible after the final study follow-up visit as long as at least three months have passed since the final intervention of the trial.\]
13. Visual impairment that limits walking ability.
14. Six-minute walk distance of \<400 feet or \>1700 feet.
15. Participation in a supervised treadmill exercise program or a cardiac rehabilitation program in previous three months or planning to begin a supervised treadmill exercise program or a cardiac rehabilitation program in the next five months.
16. Unwilling to avoid red light therapy outside of study participation.
17. Baseline blood pressure \<100/45.
18. In addition to the above criteria, investigator discretion will be used to determine if the trial is unsafe or not a good fit for the potential participant.

Where it's running

• Northwestern University
  Chicago, Illinois, United States Recruiting

Study contacts

• Study coordinator: Mary McDermott, MD
• Email: mdm608@northwestern.edu
• Phone: 13125036419

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercises to Improve Lower-Leg Blood Flow and Wound Healing

  This program will test whether a tailored exercise system can improve lower-leg circulation and help chronic wounds in older adults with poor peripheral blood flow.

  Recruiting National Health Research Institutes, Taiwan · Taipei · NCT07330635

• Helping people walk better after leg revascularization for peripheral artery disease

  This project will see if adding a home-based walking program or taking nitrate-rich beetroot juice after leg revascularization helps people with peripheral artery disease walk farther and faster.

  Recruiting at 8 sites Phase 3 Northwestern University · Tucson, Arizona and 7 other locations · NCT06686121

• Using Fisetin to Improve Walking in Patients with Peripheral Arterial Disease

  This study is testing if Fisetin can help people with peripheral artery disease walk better by reducing certain old cells in their bodies.

  Recruiting Phase 2 Northwestern University · Chicago, Illinois · NCT06399809

• Exercise and beetroot juice for improving walking in patients with PAD

  This study is testing whether combining treadmill and home exercises with beetroot juice can help older patients with peripheral artery disease walk farther and feel better.

  Recruiting at 3 sites Phase 3 Northwestern University · Chicago, Illinois and 2 other locations · NCT06032065

• Aquatic power training dosing strategies and creatine in older adults

  This trial tests whether different aquatic power training dosing methods and creatine supplementation help improve function in community-dwelling adults aged 60 and older.

  Recruiting University of Valencia · Valencia, Valencia · NCT07914270

• Intergenerational Interaction Program for Nursing Home Residents and Nursing Students

  A 6-week program pairs nursing home residents with nursing students to see if weekly joint activities can increase joy and reduce loneliness for older adults and lessen ageism in students.

  Recruiting Acibadem University · Istanbul · NCT07904299

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.